Clinical Trials Browser

Phase 3 × Neoplasms × Etoposide × Clear all

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00083551 2015-11-23

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

Phase 3 Completed

668 enrolled 7 charts

Plasma cell

Multiple Myeloma, Neoplasms

NCT00109031 2014-09-15

Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)

Phase 3 Completed

47 enrolled 19 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Neoplasms

Clinical Trials

SPINOZA

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)